Lactose India [LACTOSE] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Lactose India
BSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Lactose India wins in 13 metrics, Sequent Scientific wins in 5 metrics, with 0 ties. Lactose India appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lactose India | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.87 | 153.95 | Lactose India |
| Price-to-Book Ratio | 1.99 | 6.28 | Lactose India |
| Debt-to-Equity Ratio | 96.75 | 62.47 | Sequent Scientific |
| PEG Ratio | N/A | 1.29 | N/A |
| EV/EBITDA | 10.40 | 29.43 | Lactose India |
| Profit Margin (TTM) | 3.47% | 1.85% | Lactose India |
| Operating Margin (TTM) | 7.82% | 7.56% | Lactose India |
| EBITDA Margin (TTM) | 7.82% | 7.56% | Lactose India |
| Return on Equity | 8.79% | 2.84% | Lactose India |
| Return on Assets (TTM) | 3.87% | 1.37% | Lactose India |
| Free Cash Flow (TTM) | $-146.70M | $442.73M | Sequent Scientific |
| 1-Year Return | -37.72% | 5.41% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 0.92 | 2.76 | Lactose India |
| Enterprise Value | $1.66B | $48.87B | Sequent Scientific |
| EV/Revenue Ratio | 1.32 | 3.05 | Lactose India |
| Gross Profit Margin (TTM) | 34.06% | 46.86% | Sequent Scientific |
| Revenue per Share (TTM) | $101 | $64 | Lactose India |
| Earnings per Share (Diluted) | $4.06 | $1.15 | Lactose India |
| Beta (Stock Volatility) | 0.49 | 0.91 | Lactose India |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lactose India vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lactose India | 8.04% | 2.75% | 1.26% | -2.43% | -16.76% | -54.72% |
| Sequent Scientific | -0.15% | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lactose India | -37.72% | 39.89% | 295.66% | 150.44% | 493.49% | 16,900.00% |
| Sequent Scientific | 5.41% | 52.52% | 30.60% | 19.28% | 19.28% | 19.28% |
Performance & Financial Health Analysis: Lactose India vs Sequent Scientific
| Metric | LACTOSE | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.17B | ₹44.30B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 8,893 | 688,982 |
| 90 Day Avg. Volume | 6,281 | 534,520 |
| Last Close | ₹100.30 | ₹175.85 |
| 52 Week Range | ₹84.27 - ₹247.40 | ₹117.35 - ₹240.70 |
| % from 52W High | -59.46% | -26.94% |
| All-Time High | ₹247.40 (Dec 09, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -59.46% | -47.74% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.13% |
| Quarterly Earnings Growth | -0.34% | 1.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.02% |
| Operating Margin (TTM) | 0.08% | 0.08% |
| Return on Equity (TTM) | 0.09% | 0.03% |
| Debt to Equity (MRQ) | 96.75 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹46.65 | ₹28.19 |
| Cash per Share (MRQ) | ₹3.92 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹-49,118,000 | ₹360.47M |
| Levered Free Cash Flow (TTM) | ₹51.63M | ₹218.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Lactose India vs Sequent Scientific
| Metric | LACTOSE | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.87 | 153.95 |
| Forward P/E | N/A | 35.06 |
| PEG Ratio | N/A | 1.29 |
| Price to Sales (TTM) | 0.92 | 2.76 |
| Price to Book (MRQ) | 1.99 | 6.28 |
| Market Capitalization | ||
| Market Capitalization | ₹1.17B | ₹44.30B |
| Enterprise Value | ₹1.66B | ₹48.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.32 | 3.05 |
| Enterprise to EBITDA | 10.40 | 29.43 |
| Risk & Other Metrics | ||
| Beta | 0.49 | 0.91 |
| Book Value per Share (MRQ) | ₹46.65 | ₹28.19 |
Financial Statements Comparison: Lactose India vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LACTOSE | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹277.71M | ₹4.41B |
| Cost of Goods Sold | ₹183.11M | ₹2.35B |
| Gross Profit | ₹94.60M | ₹2.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹20.16M | ₹333.50M |
| EBITDA | ₹37.81M | ₹505.30M |
| Pre-Tax Income | ₹5.49M | ₹255.20M |
| Income Tax | ₹-938,000 | ₹79.50M |
| Net Income (Profit) | ₹6.42M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LACTOSE | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹44.81M | ₹626.60M |
| Total Current Assets | ₹573.26M | ₹8.74B |
| Total Current Liabilities | ₹448.90M | ₹5.05B |
| Long-Term Debt | ₹259.33M | ₹3.00B |
| Total Shareholders Equity | ₹587.40M | ₹7.70B |
| Retained Earnings | N/A | ₹1.25B |
| Property, Plant & Equipment | ₹522.71M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LACTOSE | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LACTOSE | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 8,893 | 688,982 |
| Average Daily Volume (90 Day) | 6,281 | 534,520 |
| Shares Outstanding | 12.59M | 249.89M |
| Float Shares | 5.03M | 117.77M |
| % Held by Insiders | 0.59% | 0.53% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Lactose India vs Sequent Scientific
| Metric | LACTOSE | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |